Table 1.

Characteristics of COVID-19 patients

Ref	Publication date	Age (years)	Sex	Country	Comorbidities	COVID-19 Sx	Severity of COVID-19	COVID-19 therapy	Steroids	Hospital admission	ICU admission	Mech. vent	Timing of Crypto Dg (D)a
[9]	8/2021	75	M	USA	HTN, DM, OA, obesity	Fever, SOB	Severe	Remdesivir	Yes	Yes	Yes	Yes	Postmortem
[10]	8/2021	55	M	Germany	A-fib, dilated cardiomyopathy	SOB	Severe	N/A	Yes	Yes	Yes	Yes	D13
[11]	6/2021	73	F	USA	None	Fever, SOB	Severe	N/A	Yes	Yes	Yes	Yes	D17
[12]	12/2020	60	M	Qatar	HTN, DM, IHD	SOB	Severe	Tocilizumab	Yes	Yes	Yes	Yes	D48
[13]	12/2020	24	M	USA	HIV	SOB, fatigue, HA	Mild	N/A	No	Yes	Yes	No	D5
[14]	10/2020	75	M	Brazil	HTN, kidney transplant, liver cirrhosis	Cough, SOB	Severe	N/A	Yes	Yes	Yes	Yes	Postmortem
[15]	1/2021	78	M	USA	HTN, COPD	Fever, SOB, HA	Severe	Remdesivir	Yes	Yes	Yes	Yes	D22
[16]	4/2021	76	F	USA	HTN	Diarrhea, weakness, confusion	Severe	Remdesivir, tocilizumab	Yes	Yes	Yes	Yes	D49
[17]	12/2021	78	M	Spain	HTN, DM, CKD	Fever, SOB, asthenia	Severe	N/A	Yes	Yes	Yes	Yes	D75
[18]	3/2022	59	M	USA	COPD, DM, liver cirrhosis	SOB	Severe	N/A	Yes	Yes	Yes	Yes	D33
[19]	5/2021	76	F	USA	HTN, osteoarthritis	Diarrhea, weakness, confusion	Severe	Remdesivir, tocilizumab	Yes	Yes	Yes	Yes	D44
[20]	01/2022	57	M	USA	HTN	Fever, SOB	Severe	Remdesivir	Yes	Yes	Yes	Yes	D36
[21]	11/2021	59	M	USA	HTN, DM, obesity	Fever, SOB	Severe	Remdesivir	Yes	Yes	Yes	Yes	D10

A-fib atrial fibrillation, COPD chronic obstructive pulmonary disease, Crypto cryptococcosis, Dg diagnosis, F female, HIV human immunodeficiency virus, IHD ischemic heart disease, HTN hypertension, D (days), DM diabetes mellitus, HA headache, M male, Mech. vent. mechanical ventilation, OA osteoarthritis, Sx symptoms, SOB shortness of breath, Ref reference

^aTiming of cryptococcosis diagnosis from the time of COVID-19 diagnosis